Rchr
J-GLOBAL ID:201801006718546695   Update date: Feb. 01, 2024

Takaichi Shohei

Takaichi Shohei
Affiliation and department:
Other affiliations (2):
  • Mayo Clinic  Department of Gastroenterology and Hepatology 
  • Osaka University
Research field  (1): Other
Research theme for competitive and other funds  (2):
  • 2021 - 2024 3次元血管化膵組織による1型糖尿病に対する新規膵島移植治療の開発
  • 2019 - 2021 Construction of three-dimensional vascularized pancreatic tissue using layer-by-layer method
Papers (11):
  • Keisuke Toya, Yoshito Tomimaru, Shogo Kobayashi, Akima Harada, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Takehiro Noda, Hidenori Takahashi, Takeshi Kado, et al. Efficacy of Autologous Skeletal Myoblast Cell Sheet Transplantation for Liver Regeneration in Liver Failure. Transplantation. 2023. 107. 8. e190-e200
  • Shohei Takaichi, Yoshito Tomimaru, Shogo Kobayashi, Keisuke Toya, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Takehiro Noda, Hidenori Takahashi, Tadafumi Asaoka, et al. ASO Visual Abstract: Change Impact of Body Composition during Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy. Annals of surgical oncology. 2023. 30. 4. 2471-2472
  • Shohei Takaichi, Yoshito Tomimaru, Shogo Kobayashi, Keisuke Toya, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Takehiro Noda, Hidenori Takahashi, Tadafumi Asaoka, et al. Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy. Annals of surgical oncology. 2022. 30. 4. 2458-2468
  • Shohei Takaichi, Yoshito Tomimaru, Shogo Kobayashi, Keisuke Toya, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Takehiro Noda, Hidenori Takahashi, Tadafumi Asaoka, et al. ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy Changes Body Composition Influencing Long-term Outcomes. Annals of surgical oncology. 2022. 30. 4. 2469-2470
  • Shohei Takaichi, Yoshito Tomimaru, Takami Akagi, Shogo Kobayashi, Yasunari Fukuda, Keisuke Toya, Tadafumi Asaoka, Yoshifumi Iwagami, Daisaku Yamada, Hirofumi Akita, et al. Three-dimensional Vascularized β-cell Spheroid Tissue Derived From Human Induced Pluripotent Stem Cells for Subcutaneous Islet Transplantation in a Mouse Model of Type 1 Diabetes. Transplantation. 2022. 106. 1. 48-59
more...
MISC (46):
  • Shohei Takaichi, Dong-Gi Mun, Jennifer L. Tomlinson, Amro M. Abdelrahman, Danielle M. Carlson, Alaa Abou Daher, Nathan W. Werneburg, Xinyan Wu, Akhilesh Pandey, Gregory J. Gores, et al. Axl inhibition sensitizes cholangiocarcinoma cells to cytotoxic chemotherapy. Cancer Research. 2023. 83. 7_Supplement. 4996-4996
  • Shohei Takaichi, Jennifer L Tomlinson, Mincheng Yu, Amro M Abdelrahman, Nathan W Werneburg, Gregory J Gores, Rory L Smoot. Effect of AXL on cholangiocarcinoma survival and sensitivity to cytotoxic chemotherapy. Journal of Clinical Oncology. 2023. 41. 4_suppl. 591-591
  • 高市 翔平, 富丸 慶人, 小林 省吾, 伊藤 壽記, 遠矢 圭介, 佐々木 一樹, 岩上 佳史, 山田 大作, 秋田 裕史, 野田 剛広, et al. 膵臓移植〜長期成績向上に向けて〜 脳死膵腎同時移植症例における術前の腹部大動脈石灰化が予後に与える影響についての検討. 移植. 2021. 56. 総会臨時. SSY1-5
  • Takaichi Shohei, Tomimaru Yoshito, Kobayashi Shogo, Hagiwara Kuniko, Iwagami Yoshifumi, Akita Hirofumi, Noda Takehiro, Gotoh Kunihito, Kenmochi Takashi, Doki Yuichiro, et al. Acceptance/declineおよび移植後の膵グラフトの生存率に基づいて膵臓の提供を受け入れるかどうかを再検討すること(Reconsideration for indication of acceptance for pancreas offers based on our acceptance/decline and posttransplant pancreas graft survival). 日本肝胆膵外科学会・学術集会プログラム・抄録集. 2021. 32回. 572-572
  • 高市 翔平, 富丸 慶人, 小林 省吾, 秋田 裕史, 岩上 佳史, 野田 剛広, 後藤 邦仁, 土岐 祐一郎, 江口 英利. 膵癌に対する術前化学放射線療法における治療前後の体組成評価の臨床的意義. 日本消化器外科学会総会. 2020. 75回. P289-6
more...
Awards (1):
  • 2023/07 - メイヨークリニック 2023 ASCO Breakthrough Merit Award
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page